Table 1.
Adverse events outcomes.
| Year | Reporting agency | Adverse events outcomes (measures and sources) |
|---|---|---|
| 2015 | WHO, U.S. Reports | 12 million adverse events in the U.S.; ~10% of hospitalized patients in high-income countries were affected. (Source: WHO, Makary and Daniel, 2016) |
| 2016 | WHO | 134 million adverse events globally, primarily in LMICs. (Source: WHO, 2019) |
| 2017 | WHO | 134 million adverse events globally. (Source: WHO, 2029) |
| 2018 | OECD | 15% of all hospital expenditures were linked to adverse events. (Source: OECD Report, 2018) |
| 2019 | NHS | 1.8 million adverse events were reported in English hospitals. (Source: NHS, 2019) |
| 2020 | WHO | Adverse events increased due to COVID-19, with 134 million annually. (Source: WHO, 2020) |
| 2021 | WHO | 10%−12% of patients in high-income countries experienced adverse events. (Source: WHO, 2024) |
| 2022 | WHO | 10% of patients in high-income countries experienced adverse events. (Source: WHO, 2024) |
| 2023 | WHO | Continued high rates of adverse events were reported. (Source: WHO, 2024) |
| 2024 | WHO | Projected 134 million adverse events globally. (Source: WHO, 2024) |